Good question
The Pyo 2007 study directly compared tripeptide-copper complexes for their effects on human hair follicles
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Available in convenient multi-packs (1, 2, 5, 10, and 20 packs) to suit your needs while offering the best wholesale pricing and cost efficiency
Some focus on small-scale microscopic details, while others examine larger-scale tissue healing